Guadalupe M.L. Guerrero-Avendaño, Coordinación Estatal, IMSS Bienestar, Estado de México; Academia Nacional de Medicina; Academia Mexicana de Cirugía; Ciudad de México, México
Ana L. Sánchez-Sandoval, Servicio de Medicina Genómica, Hospital General de México Dr. Eduardo Liceaga; Departamento de Bioquímica, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Ciudad de México. México
Eira V. Barrón-Palma, Servicio de Medicina Genómica, Hospital General de México Dr. Eduardo Liceaga; Departamento de Bioquímica, Facultad de Medicina, UNAM. Ciudad de México. México
Currently, we are in a global context where women’s human rights, particularly equality and autonomy, have gained increasing relevance. At the same time, national and international documents have been updated, and knowledge about violence against women has expanded, recognizing its various forms (physical, psychological, and sexual) as well as its different settings (family, community, workplace, and healthcare). This highlights that many aspects of women’s health are deeply linked to inequality and violence. Investment in biomedical research has a direct impact on population health. If there were no lag in research on women’s health, this should also be reflected in women’s life expectancy. However, it is essential to prioritize the concept of “healthy life expectancy” in order to reach more accurate conclusions. To answer the questions of whether there is a lag in research on women’s health and how this lag affects their well-being we propose addressing three key areas: quality-adjusted life expectancy, the evaluation of research projects that include and analyze data by sex, and equitable participation of women in science. Finally, understanding the current landscape of research by and for women in health is essential for designing strategies that help eliminate inequality and violence against women.
Keywords: Equity. Women´s health. Women. Science.